Sage Journals: Discover world-class research

Retricted access

Research article

First published 2021-11

Companies’ statements about drugs withdrawn from the Canadian market: A descriptive analysis

Joel Lexchin

International Journal of Risk & Safety in Medicine

Retricted access

Other

First published 2000-7

History and Accomplishments of the Inter-Company Collaboration for AIDS Drug Development

David W. Barry, Linda M. Distlerath

Therapeutic Innovation & Regulatory Science

Open access

Research article

First published 2022-7

A Game Theoretic Analysis of Competition Between Vaccine and Drug Companies during Disease Contraction and Recovery

Kjell Hausken, Mthuli Ncube

Medical Decision Making

Retricted access

Research article

First published 1977-9

The Function of Drug Company Representatives

Elina Hemminki, Terttu Pesonen

Scandinavian Journal of Public Health

Open access

Research article

First published 2022-3

Brand drug companies impeding generic drug company access to product samples: Estimated prevalence and impact on drug costs

Paul Grootendorst

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Retricted access

Research article

First published 1983-4

Provision of Drug Information — A Company Report

J. Michael Burns, George Phillips, Brandt Rowles

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 1992-3

Ethical issues in the relationship between American physicians and drug companies

Marshall B. Kapp

International Journal of Risk & Safety in Medicine

Retricted access

Research article

First published 2000-7

The Influences of Drug Companies' Advertising Programs on Physicians

Dilek Güldal, Semih Şmin

International Journal of Social Determinants of Health and Health Services

Retricted access

Research article

First published 1982-7

The Multinational Drug Companies in Zaire: Their Adverse Effect on Cost and Availability of Essential Drugs

Harold Glucksberg, Jack Singer

International Journal of Social Determinants of Health and Health Services

Retricted access

Research article

First published 2009-11

Can the relationship between doctors and drug companies ever be a healthy one?

Emma D'Arcy, Ray Moynihan

International Journal of Risk & Safety in Medicine

Search results